PLx Pharma Inc.
PLXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.53M
Close$
Share Statistics
| Market cap | $2.53 Million |
|---|---|
| Enterprise Value | $-23,299,020.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.18 |
| Beta | 3.92 |
| Outstanding Shares | 28,603,426 |
Return
| Return on Equity | -57.80% |
|---|---|
| Return on Assets | -45.58% |
| Return on Invested Capital | -148.67% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.06 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -5.13 |
| Enterprise Value to EBIT | 0.58 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PLx Pharma Inc.
PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform ...